Amy Easter is a European and Chartered (UK) patent attorney with extensive experience in both in-house and private practice roles focused on biologics and biotechnology, particularly in antibody and cell therapy technologies. They completed a PhD in Medicine at the University of Cambridge, where their research investigated the role of TRUSS in TNF-R1 signaling and its implications for inflammatory lung diseases. Amy's career includes positions at Kilburn & Strode LLP, MSD, and Quell Therapeutics, and they are currently a Senior Patent Attorney at AstraZeneca. Known for their skilled communication and ability to collaborate across functional teams, they excel in aligning patent strategy with R&D and business objectives.
This person is not in the org chart
This person is not in any teams
This person is not in any offices